Medicover AB (publ) (STO: MCOV.B)
Sweden
· Delayed Price · Currency is SEK 173.60
-0.60 (-0.34%)
Nov 19, 2024, 5:29 PM CET
Medicover AB Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1,998 | 1,746 | 1,510 | 1,377 | 997.8 | 844.4 | Upgrade
|
| Revenue Growth (YoY) | 18.77% | 15.64% | 9.64% | 38.04% | 18.17% | 25.73% | Upgrade
|
| Cost of Revenue | 1,584 | 1,387 | 1,170 | 982.4 | 733.6 | 637.1 | Upgrade
|
| Gross Profit | 413.6 | 359.4 | 340.1 | 395 | 264.2 | 207.3 | Upgrade
|
| Selling, General & Admin | 330.3 | 297.1 | 271.4 | 232.4 | 196.2 | 157.6 | Upgrade
|
| Operating Expenses | 330.3 | 297.1 | 271.4 | 232.4 | 196.2 | 157.6 | Upgrade
|
| Operating Income | 83.3 | 62.3 | 68.7 | 162.6 | 68 | 49.7 | Upgrade
|
| Interest Expense | -58.2 | -51.4 | -34.5 | -20.1 | -18.1 | -13.7 | Upgrade
|
| Interest & Investment Income | 4.7 | 4.4 | 2.7 | 1 | 0.9 | 1.8 | Upgrade
|
| Earnings From Equity Investments | - | 0.1 | 0.2 | 1 | 0.1 | -1.9 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.1 | 1.1 | -3.3 | 1.8 | -8.4 | -0.4 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.3 | 0.2 | 2.4 | 0.3 | 0.2 | 8.9 | Upgrade
|
| EBT Excluding Unusual Items | 29.6 | 16.7 | 36.2 | 146.6 | 42.7 | 44.4 | Upgrade
|
| Merger & Restructuring Charges | -0.7 | -0.7 | -7.2 | -3.2 | -1.5 | -4.5 | Upgrade
|
| Impairment of Goodwill | -16.4 | - | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -3.2 | 0.4 | 1.3 | -5.8 | Upgrade
|
| Gain (Loss) on Sale of Assets | 7.8 | 7.8 | - | - | - | - | Upgrade
|
| Asset Writedown | -0.2 | -0.2 | -6.3 | - | -5.2 | -0.8 | Upgrade
|
| Pretax Income | 20.1 | 23.6 | 19.5 | 143.8 | 37.3 | 33.3 | Upgrade
|
| Income Tax Expense | 4.3 | 5.2 | 5.8 | 37.2 | 10 | 8.6 | Upgrade
|
| Earnings From Continuing Operations | 15.8 | 18.4 | 13.7 | 106.6 | 27.3 | 24.7 | Upgrade
|
| Minority Interest in Earnings | 3.9 | -0.8 | -1.9 | -4.8 | -1.5 | -2.2 | Upgrade
|
| Net Income | 19.7 | 17.6 | 11.8 | 101.8 | 25.8 | 22.5 | Upgrade
|
| Net Income to Common | 19.7 | 17.6 | 11.8 | 101.8 | 25.8 | 22.5 | Upgrade
|
| Net Income Growth | 146.25% | 49.15% | -88.41% | 294.57% | 14.67% | 0.90% | Upgrade
|
| Shares Outstanding (Basic) | 150 | 149 | 149 | 148 | 142 | 133 | Upgrade
|
| Shares Outstanding (Diluted) | 150 | 150 | 149 | 148 | 142 | 133 | Upgrade
|
| Shares Change (YoY) | 0.40% | 0.47% | 0.41% | 4.66% | 6.31% | - | Upgrade
|
| EPS (Basic) | 0.13 | 0.12 | 0.08 | 0.69 | 0.18 | 0.17 | Upgrade
|
| EPS (Diluted) | 0.13 | 0.12 | 0.08 | 0.69 | 0.18 | 0.17 | Upgrade
|
| EPS Growth | 146.84% | 49.16% | -88.48% | 276.93% | 8.33% | 0.60% | Upgrade
|
| Free Cash Flow | 122 | 94.5 | 29.6 | 114.5 | 82.6 | 24.1 | Upgrade
|
| Free Cash Flow Per Share | 0.81 | 0.63 | 0.20 | 0.77 | 0.58 | 0.18 | Upgrade
|
| Dividend Per Share | 0.120 | 0.120 | 0.120 | 0.120 | 0.070 | - | Upgrade
|
| Dividend Growth | 0% | 0% | 0% | 71.43% | - | - | Upgrade
|
| Gross Margin | 20.70% | 20.58% | 22.52% | 28.68% | 26.48% | 24.55% | Upgrade
|
| Operating Margin | 4.17% | 3.57% | 4.55% | 11.80% | 6.81% | 5.89% | Upgrade
|
| Profit Margin | 0.99% | 1.01% | 0.78% | 7.39% | 2.59% | 2.66% | Upgrade
|
| Free Cash Flow Margin | 6.11% | 5.41% | 1.96% | 8.31% | 8.28% | 2.85% | Upgrade
|
| EBITDA | 199.5 | 156.3 | 152.7 | 220.6 | 114.4 | 85 | Upgrade
|
| EBITDA Margin | 9.99% | 8.95% | 10.11% | 16.02% | 11.47% | 10.07% | Upgrade
|
| D&A For EBITDA | 116.2 | 94 | 84 | 58 | 46.4 | 35.3 | Upgrade
|
| EBIT | 83.3 | 62.3 | 68.7 | 162.6 | 68 | 49.7 | Upgrade
|
| EBIT Margin | 4.17% | 3.57% | 4.55% | 11.80% | 6.81% | 5.89% | Upgrade
|
| Effective Tax Rate | 21.39% | 22.03% | 29.74% | 25.87% | 26.81% | 25.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.